Search hospitals > California > Loma Linda

Loma Linda University Medical Center

Claim this profile
Loma Linda, California 92354
Global Leader in Skin Cancer
Global Leader in Relapse
Conducts research for Cancer
Conducts research for T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
449 reported clinical trials
32 medical researchers
Photo of Loma Linda University Medical Center in Loma LindaPhoto of Loma Linda University Medical Center in Loma Linda

Summary

Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Skin Cancer, Relapse, Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 971 conditions. There are 32 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.

Area of expertise

1Skin Cancer
Global Leader
Loma Linda University Medical Center has run 57 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage III
2Relapse
Global Leader
Loma Linda University Medical Center has run 52 trials for Relapse. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Loma Linda University Medical Center

Lung Cancer
Brain Tumor
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Non-Small Cell Lung Cancer
Wilms Tumor
Testicular cancer
T-Lymphoblastic Leukemia/Lymphoma
Skin Cancer
Relapse
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Thoracotomy vs Thoracoscopy

for Metastatic Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Loma Linda University Medical Center?
Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Skin Cancer, Relapse, Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma and other specialties. Loma Linda University Medical Center is involved with conducting 449 clinical trials across 971 conditions. There are 32 research doctors associated with this hospital, such as Albert Kheradpour, Hamid R. Mirshahidi, Mark E. Reeves, and Hisham Abdel-Azim, MD.
Where is Loma Linda University Medical Center located?
**Loma Linda University Medical Center** - **Address:** 11234 Anderson St, Loma Linda, CA 92354 - **Directions:** Take the I-10 E to exit 62 for Anderson St in Loma Linda, then turn left onto Anderson St. **Loma Linda University Medical Center-Murrieta** - **Address:** 28062 Baxter Rd, Murrieta, CA 92563 - **Directions:** Head to 28062 Baxter Rd, Murrieta via I-15 N and CA-79 S.
Who should I call to ask about financial aid or insurance network?
**Loma Linda University Medical Center Financial Assistance and Insurance Inquiries:** - For financial assistance, including policies and application processes, contact the billing department at **909-651-4177**. They assist uninsured or underinsured patients with hospital bill concerns. - For insurance-related questions, including billing, patient balances, and claim submissions, call **909-651-4177**. Note: Most physicians and independent healthcare providers will issue separate bills.
What insurance does Loma Linda University Medical Center accept?
Loma Linda University Medical Center accepts a broad spectrum of insurance plans, such as popular HMOs and PPOs, Inland Empire Health Plan (IEHP), Medi-Cal, and Medicare. They are also part of the Blue Shield HMO and PPO networks, ensuring access to their medical centers, urgent cares, and primary care providers. It's advised to verify coverage with your insurance company directly.
What awards or recognition has Loma Linda University Medical Center received?
Loma Linda University Medical Center is renowned for its groundbreaking medical achievements and has been awarded $85 million in extramural awards for research in the last fiscal year. The center is celebrated for milestones including the first infant heart transplant, pioneering the use of a proton accelerator for cancer treatment, and inventing a nerve block technique in dentistry. It boasts prestigious accolades such as Comprehensive Stroke Center Certification, Quality Accredited Cancer Program by the American College of Surgeons, and Magnet Recognition for excellence in nursing.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security